Thermal-based laser may treat stress urinary incontinence

Thermal-based laser may treat stress urinary incontinence

(HealthDay)—Noninvasive erbium:yttrium-aluminum-garnet (Er:YAG) laser treatment appears promising for stress urinary incontinence (SUI) in women, according to a study published online Sept. 21 in Lasers in Surgery and Medicine.

Urška B. Ogrinc, M.D., from the University of Ljubljana in Slovenia, and colleagues evaluated the noninvasive Er:YAG laser as a potential treatment strategy for 175 (mean age, 49.7 years) with SUI (66 percent of women) and mixed UI (MUI; 34 percent).

The researchers found that based on an average of 2.5 procedures for each woman (separated by a two-month period), the Incontinence Severity Index scores decreased significantly from pretreatment levels for all severities (P < 0.001). Overall, more than three-quarters of patients diagnosed with SUI (77 percent) experienced significant improvement after , while 34 percent of women with MUI showed no UI after one year of follow-up. Outcomes were not affected by age. No major adverse effects were reported.

"The results of our study have shown that new noninvasive Er:YAG laser could be regarded as a promising additional strategy for SUI, with at least one year [of] lasting positive effects," the authors write. "On the other hand, it does not seem appropriate for treating MUI."


Explore further

Fractional, ablative er:YAG laser akin for skin resurfacing

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Lasers in Surgery and Medicine

Copyright © 2015 HealthDay. All rights reserved.

Citation: Thermal-based laser may treat stress urinary incontinence (2015, September 29) retrieved 20 October 2021 from https://medicalxpress.com/news/2015-09-thermal-based-laser-stress-urinary-incontinence.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
5 shares

Feedback to editors